| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |